Sensei Biotherapeutics, Inc. · NASDAQ:SNSE
Peyer James sold 25,000 Sensei Biotherapeutics, Inc. shares (Form 4)
Traded Jun 1, 2026 · Filed Jun 1, 2026
On Jun 1, 2026, Peyer James (10% owner, See remarks below) sold 25,000 Sensei Biotherapeutics, Inc. shares at an average US$20.02 for US$501K, leaving 130,142 shares. Filed Jun 1, 2026 (Form 4).
- Sold
- 25,000 shares
- Price
- US$20.02 average (US$20.00 to US$21.14)
- Value
- US$501K
- Holding after
- 130,142 shares
- Trading plan
- No
- Role
- 10% owner, See remarks below
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Sale | 24,524 | US$20.00 | 130,618 | Direct |
| Jun 1, 2026 | Common Stock | Sale | 476 | US$21.14 | 130,142 | Direct |
Source
Related
- Sensei Biotherapeutics, Inc.
- Peyer James
- Sensei Biotherapeutics, Inc. shareholders
- Schedule 13G/A · Stempoint Capital LP · Aug 14, 2026
- Schedule 13G · VK Services, LLC · Aug 14, 2026
- Schedule 13G/A · Trails Edge Capital Partners, LP · Aug 14, 2026
- Schedule 13G/A · Caligan Partners LP · Aug 14, 2026
- Schedule 13G · Montanova Capital, LLC · Jun 23, 2026